Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Elizabeth Schultz"'
Autor:
Andrew Poklepovic, Yuesheng Qu, Molly Dickinson, Michael C. Kontos, Maciej Kmieciak, Elizabeth Schultz, Dipankar Bandopadhyay, Xiaoyan Deng, Rakesh C. Kukreja
Publikováno v:
Cardio-Oncology, Vol 4, Iss 1, Pp 1-11 (2018)
Abstract Background Doxorubicin chemotherapy is used across a range of adult and pediatric malignancies. Cardiac toxicity is common, and dysfunction develops over time in many patients. Biomarkers used for predicting late cardiac dysfunction followin
Externí odkaz:
https://doaj.org/article/eb47fc70073e4307905eac93493582d8
Autor:
Kylan Rice and, Elizabeth Schultz
Publikováno v:
A New Companion to Herman Melville. :506-511
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95e41b5c7498aa82d18887449c6f5c9b
https://doi.org/10.1002/9781119668565.ch41
https://doi.org/10.1002/9781119668565.ch41
Autor:
Anas Eranthodi, Dianevys González-Peña Fundora, Ana Priscilla Montenegro Alonso, Guus Bakkeren, Rajagopal Subramaniam, Thérèse Ouellet, Chris Rampitsch, Marshall Smith, Ravinder K. Goyal, Elizabeth Schultz, Nora A. Foroud
Publikováno v:
Canadian Journal of Plant Pathology. 44:577-595
Fusarium graminearum is a mycotoxin-producing pathogen involved in Fusarium head blight (FHB) disease of cereals, and is responsible for compromising grain yield and quality.Over the course of infection, the fungus secretes various metabolites and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99efafb28b52dccdd4c0302c845656c4
https://doi.org/10.1080/07060661.2022.2044910
https://doi.org/10.1080/07060661.2022.2044910
Autor:
Jonas Dora, Michele R Smith, Katherine Seldin, Megan Elizabeth Schultz, Adam M. Kuczynski, Diego J Moss, Ryan William Carpenter, Kevin Michael King
Although frequently hypothesized, the evidence for associations between affect and marijuana use in everyday life remains ambiguous. Inconsistent findings across existing work may be due, in part, to differences in study design and analytic decisions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98e4bd87a201c16d2ffbef1d80d63555
https://doi.org/10.31234/osf.io/j375w
https://doi.org/10.31234/osf.io/j375w
Autor:
Jonas Dora, Adam M. Kuczynski, Megan Elizabeth Schultz, Samuel Acuff, James Murphy, Kevin Michael King
Objective: Influential theoretical models hypothesize that alcohol use is an especially potent reinforcer when used as a strategy to cope with negative affect. Although the evidence for this idea in observational data is weak, some experimental evide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86115c73b6c64b9d776eb15f674ae4d8
https://doi.org/10.31234/osf.io/eh9j4
https://doi.org/10.31234/osf.io/eh9j4
Publikováno v:
Brain and neuroscience advances. 6
It remains unclear whether the negative reinforcement pathway to problematic drinking exists, and if so, for whom. One idea that has received some support recently is that people who tend to act impulsively in response to negative emotions (i.e. peop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a10552c71d7b2046925d84bb77376e8c
https://pubmed.ncbi.nlm.nih.gov/35237726
https://pubmed.ncbi.nlm.nih.gov/35237726
Autor:
Elizabeth Schultz
Publikováno v:
Leviathan. 21:7-96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c746afcf67812044dd27a396d707fa16
https://doi.org/10.1353/lvn.2019.0001
https://doi.org/10.1353/lvn.2019.0001
Autor:
Ehab Atallah, Ilana R. Yurkiewicz, Madelyn Burkart, Mark R. Litzow, Emily Curran, Anjali S. Advani, Michaela Liedtke, Shira Dinner, Shukaib Arslan, Ibrahim Aldoss, Caitlin Siebenaller, Anand Patel, Nikolai A. Podoltsev, Martha Wadleigh, Elizabeth Schultz, Suresh Kumar Balasubramanian, Mehrdad Hefazi, Muhammad Ali Khan, Jay Yang, Aniko Szabo, Rory M. Shallis, Talha Badar, Ryan J. Mattison
Publikováno v:
Blood Adv
The availability and use of blinatumomab symbolizes a paradigm shift in the management of B-cell acute lymphoblastic leukemia (ALL). We conducted a retrospective multicenter cohort analysis of 239 ALL patients (227 relapsed refractory [RR], n = 227;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f192e159fc9d190e1b10ea5eee20079
https://europepmc.org/articles/PMC7252553/
https://europepmc.org/articles/PMC7252553/
Autor:
Elizabeth Schultz, Martha Wadleigh, Michaela Liedtke, Ibrahim Aldoss, Nikolai A. Podoltsev, Madelyn Burkart, Suresh Kumar Balasubramanian, Mehrdad Hefazi, Amy Wang, Caitlin Siebenaller, Ehab Atallah, Shira Dinner, Shukaib Arslan, Mark R. Litzow, Eric Kuo, Talha Badar, Anjali S. Advani, Emily Curran, Jay Yang, Rory M. Shallis, Aniko Szabo, Ryan J. Mattison
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(8)
Background Inotuzumab ozogamicin (InO) is an anti-CD22 monoclonal antibody–drug (calicheamicin) conjugate that has shown superior efficacy compared to conventional chemotherapy in relapsed/refractory (RR) B-cell acute lymphocytic leukemia (ALL) pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfd0aeedf49907a86191916959852ad9
https://pubmed.ncbi.nlm.nih.gov/32291234
https://pubmed.ncbi.nlm.nih.gov/32291234